Why the study?
Does external application of a cilostazol-eluting film reduce neointimal hyperplasia at anastomotic sites in a canine femoral artery model?
Does external application of a cilostazol-eluting film reduce neointimal hyperplasia at anastomotic sites in a canine femoral artery model?
External application of a cilostazol-eluting film significantly suppressed neointimal hyperplasia at arterial anastomotic sites in a canine model, offering a potential strategy to improve long-term graft patency.
Answers are grounded in this paper and cite their sources.
May support local cilostazol delivery to limit anastomotic hyperplasia in preclinical models; leaves open translation to human graft patency.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kagatani et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: